[Congressional Bills 106th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4015 Introduced in House (IH)]







106th CONGRESS
  2d Session
                                H. R. 4015

   To amend the Public Health Service Act to provide for Alzheimer's 
                 clinical research and training awards.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             March 16, 2000

  Mr. Markey (for himself and Mr. Smith of New Jersey) introduced the 
    following bill; which was referred to the Committee on Commerce

_______________________________________________________________________

                                 A BILL


 
   To amend the Public Health Service Act to provide for Alzheimer's 
                 clinical research and training awards.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Alzheimer's Clinical Research and 
Training Awards Act of 2000''.

SEC. 2. ALZHEIMER'S CLINICAL RESEARCH AND TRAINING AWARDS.

    Subpart 5 of part C of title IV of the Public Health Service Act 
(42 U.S.C. 285e et seq.) is amended--
            (1) by redesignating section 445I as section 445J; and
            (2) by inserting after section 445H the following section:

          ``alzheimer's clinical research and training awards

    ``Sec. 445I. (a) The Director of the Institute is authorized to 
establish and maintain the Alzheimer's disease Physician-Scientist 
program to enhance and promote the translation of new scientific 
knowledge into clinical practice toward the diagnosis, care and 
treatment of individuals with Alzheimer's disease.
    ``(b) In order to foster the application of the latest developments 
in Alzheimer's diagnosis, treatment and care, funds under this program 
shall be directed to support promising clinicians through awards for 
research, study, and practice at centers of excellence in Alzheimer 
research and treatment.
    ``(c) Research awards under subsection (b) shall be carried out in 
environments of demonstrated excellence in neuroscience, neurobiology, 
geriatric medicine, psychiatry and foster innovation and integration of 
these disciplines or other environments determined suitable by the 
Director of the Institute.
    ``(d) In addition to any other authorization of appropriations 
available for the purpose of carrying out this section, there are 
authorized to be appropriated for such purpose $2,250,000 for each of 
fiscal years 2001 through 2005.''.
                                 <all>